Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.
about
An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma.Postoperative radiotherapy in salivary ductal carcinoma: a single institution experience.High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.Salivary duct carcinoma: A clinopathological report of 11 cases.Parotid carcinoma: Current diagnostic workup and treatment.The "shield sign" in two men with metastatic salivary duct carcinoma to the skin: cutaneous metastases presenting as carcinoma hemorrhagiectoidesTreatment results of post-operative radiotherapy in patients with salivary duct carcinoma of the major salivary glandsTrastuzumab for the treatment of salivary duct carcinoma.Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid glandPostoperative radiotherapy in patients with salivary duct carcinoma: clinical outcomes and prognostic factorsEarly T Stage Salivary Duct Carcinoma: Outcomes and Implications for Patient Counseling.A 20-Year Review of 75 Cases of Salivary Duct CarcinomaTargeted therapy with trastuzumab for advanced salivary ductal carcinoma: case report and literature review.Diagnosis and management of parotid carcinoma with a special focus on recent advances in molecular biology.Salivary tumours.Perineural invasion and spread in head and neck cancer.Salivary duct carcinoma: what is already known, and can we improve survival?Systemic therapy in the management of metastatic or advanced salivary gland cancers.Recent trends in the management of minor salivary gland carcinoma.Salivary duct carcinoma responding to trastuzumab-based therapy: case report and review of the literature.Perineural Spread in Noncutaneous Head and Neck Cancer: New Insights into an Old Problem.Salivary duct carcinoma: a Danish national study.Outcomes and prognostic factors for surgery followed by modern radiation therapy in parotid gland carcinomas.Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification.HER2/neu negative salivary duct carcinoma of parotid: A case with forty months recurrence free follow up.Salivary duct carcinoma treated with cetuximab-based targeted therapy: A case report.Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation TherapyTRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland Carcinoma.Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.Management and outcome of salivary duct carcinoma in major salivary glands.Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck.Salivary duct carcinoma: Treatment, outcomes, and patterns of failure.Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.Significant and durable clinical benefit from trastuzumab in 2 patients with HER2-amplified salivary gland cancer and a review of the literature.The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2.Cytogenetic and immunohistochemical biomarker profiling of therapy-relevant factors in salivary gland carcinomas.Salivary duct carcinoma: Clinicopathologic features, morphologic spectrum, and somatic mutations.Intratumoral heterogeneity of HER2 protein and amplification of HER2 gene in salivary duct carcinoma.
P2860
Q33619720-36A3EC86-15C8-4861-855E-238A63C59E93Q34325443-FC0D3932-5F1D-4654-AE28-987E9E9CC737Q34436470-3C550A42-0825-4CD8-BE96-464CBD12E236Q35803825-770B0556-71CC-471D-BBC2-F1AC4AAC443DQ36170033-2209D9E6-0D72-4CB6-9094-69CAB648745AQ36286773-8DD604C2-877B-4E37-8A68-36EFA65AC490Q36325917-636BDE0A-CD37-44B3-ABB6-20DE4D4899FBQ36714388-2DCEBCCB-5A29-4631-8144-9B5DAB6DEEDDQ36902899-9E4FA7BD-2730-4B98-B40F-E68AEDC9220DQ37154089-C8A1A759-90EB-4CE1-90F7-B8CB15C9E167Q37254933-13B7C0B5-214A-414C-BAFB-7AD98635D493Q37275710-D01E744E-DE97-4748-8C3F-E62799069ED9Q37850379-D839DA4B-C590-4225-BE7D-4D47D82AD52DQ37880693-C3C003CC-8A64-4C31-B04B-33E6992CDD24Q37903912-939DAB14-1F08-4E16-B821-CD13D989A974Q37988567-6FE42780-F4A7-4BDD-94FB-0B763D42BDF5Q38001863-D29438A6-9CAA-4B25-AEA8-0AD511A190A0Q38007528-1A43FE44-C368-4531-89EC-4C222228A2A1Q38096338-4B1A089B-9A84-477D-987E-3431C21D1868Q38114366-BF5DECFA-70B4-434C-A55C-0B00AEF01C18Q38819708-FB0ED8D0-F552-4BA7-8879-8EEE9DD6BAADQ40046991-B357B4A5-75F2-4927-ADBA-1427CEB0B71EQ40693954-822AF6F1-7B94-45BB-A986-AE581AF7ADC2Q41708696-08639A7E-E4D2-4EBF-BA57-2B8D8AD28B53Q42039154-F6199D0B-2476-4761-A736-27B60B3C2E66Q42233857-014FF1EF-F121-4C0D-A414-7EE68F91A544Q42245011-63D83875-88FB-48E7-A73D-377250E7D02DQ42434702-4C168A70-487B-44E6-AB34-0556BFEF060BQ42936492-CC186E83-0FCB-47A0-896D-3DD0C0803EFCQ45996599-A4E687B9-EDF1-4773-86A4-896A9B1262A3Q46447217-525010A0-EE03-4719-9280-E5951C092920Q47259493-BDEC6315-B400-484F-B4F3-E4DE81F5608EQ47433338-65E75575-F057-455A-9E6A-F3DA5EB5BE83Q47569604-CC22215D-C9C4-4F6B-BD86-26C6918E7157Q47859326-38FD2FAF-FDD2-4947-A63E-84596E3C3908Q48123633-7AFCC9E1-3D0C-4F17-A9D5-E5D2EA7630A8Q49511046-1AD79CBE-86A8-4FC9-AE7C-0CB32D4BA48FQ50675747-4009F2C9-1A74-4182-A075-F1DC266A03EFQ54226554-CABCD8FC-838F-4EC3-864A-DC87A6E2912FQ54323253-92E0DFFC-4B8B-4944-9B51-1F4E35D3FFAB
P2860
Salivary duct carcinoma: a clinical and histologic review with implications for trastuzumab therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Salivary duct carcinoma: a cli ...... tions for trastuzumab therapy.
@en
type
label
Salivary duct carcinoma: a cli ...... tions for trastuzumab therapy.
@en
prefLabel
Salivary duct carcinoma: a cli ...... tions for trastuzumab therapy.
@en
P2093
P356
P1433
P1476
Salivary duct carcinoma: a cli ...... tions for trastuzumab therapy.
@en
P2093
Christian S Head
Jesse W Tan
Joel A Sercarz
Sunita Bhuta
Vishad Nabili
P2860
P304
P356
10.1002/HED.20614
P577
2007-10-01T00:00:00Z